糖尿病新世界2024,Vol.27Issue(1) :73-76.DOI:10.16658/j.cnki.1672-4062.2024.01.073

二甲双胍治疗老年糖尿病患者的临床价值

Clinical Value of Metformin in the Treatment of Elderly Patients with Dia-betes Mellitus

徐闽 王友强 臧菲菲
糖尿病新世界2024,Vol.27Issue(1) :73-76.DOI:10.16658/j.cnki.1672-4062.2024.01.073

二甲双胍治疗老年糖尿病患者的临床价值

Clinical Value of Metformin in the Treatment of Elderly Patients with Dia-betes Mellitus

徐闽 1王友强 1臧菲菲1
扫码查看

作者信息

  • 1. 潍坊市坊子区人民医院内分泌科,山东潍坊 261200
  • 折叠

摘要

目的 分析二甲双胍治疗老年糖尿病的临床价值.方法 选取2019-2021年潍坊市坊子区人民医院内分泌科收治的41例老年糖尿病患者为研究对象,按照抽签法分为观察组(n=21)与对照组(n=20).对照组实施胰岛素治疗,观察组在对照组基础上联合二甲双胍治疗,比较两组患者治疗效果、血脂指标、胰岛素分泌相关指标、血糖指标、不良反应发生率.结果 观察组治疗总有效率为95.24%高于对照组的70.00%,差异有统计学意义(P<0.05).治疗前,两组患者血脂指标比较,差异无统计学意义(P>0.05);治疗后,观察组总胆固醇、三酰甘油、低密度脂蛋白胆固醇均低于对照组,高密度脂蛋白胆固醇高于对照组,差异有统计学意义(P均<0.05).治疗前,两组患者胰岛素分泌相关指标比较,差异无统计学意义(P>0.05);治疗后,观察组空腹胰岛素、胰岛素β细胞功能指数、胰岛素抵抗指数均低于对照组,胰岛素分泌指数高于对照组,差异有统计学意义(P均<0.05).治疗前,两组患者血糖指标比较,差异无统计学意义(P>0.05);治疗后,观察组血糖指标低于对照组,差异有统计学意义(P<0.05).两组患者治疗不良反应发生率比较,差异无统计学意义(P>0.05).结论 二甲双胍治疗老年糖尿病,能够积极调整患者的身体指标,获得更加理想的血糖控制效果,且不会增加额外的治疗不良反应.

Abstract

Objective To analyze the clinical value of metformin in the treatment of diabetes mellitus in the elderly.Methods A total of 41 elderly diabetic patients admitted to the Department of Endocrinology of Weifang Fangzi Dis-trict People's Hospital from 2019 to 2021 were selected as the research objects and divided into observation group(n= 21)and control group(n=20)according to lottery method.The control group was treated with insulin,and the observa-tion group was treated with metformin on the basis of the control group.The therapeutic effect,blood lipid indexes,in-sulin secretion-related indexes,blood glucose indexes,and the incidence of adverse reactions were compared between the two groups.Results The total effective rate of treatment in the observation group was 95.24%higher than that in the control group 70.00%,the difference was statistically significant(P<0.05).Before treatment,there was no signifi-cant difference in blood lipid indexes between the two groups(P>0.05).After treatment,the total cholesterol,triglycer-ide and low density lipoprotein cholesterol in observation group were lower than those in control group,and high den-sity lipoprotein cholesterol was higher than that in control group,the differences were statistically significant(all P<0.05).Before treatment,there was no significant difference in insulin secretory indexes between the two groups(P>0.05).After treatment,fasting insulin,insulin β cell function index and insulin resistance index in observation group were lower than those in control group,and insulin secretion index was higher than those in control group,the differ-ences were statistically significant(all P<0.05).Before treatment,there was no significant difference in blood glucose index between the two groups(P>0.05).After treatment,the blood glucose index of the observation group was lower than that of the control group,and the difference was statistically significant(P<0.05).There was no significant differ-ence in the incidence of adverse reactions between the two groups(P>0.05).Conclusion Metformin treatment of geri-atric diabetes mellitus can positively adjust the patients'body indexes,obtain more ideal blood glucose control effect,and will not increase additional treatment adverse reactions.

关键词

二甲双胍/老年糖尿病/治疗效果

Key words

Metformin/Geriatric diabetes mellitus/Treatment effect

引用本文复制引用

出版年

2024
糖尿病新世界
中国病理生理学会

糖尿病新世界

影响因子:0.461
ISSN:1672-4062
参考文献量12
段落导航相关论文